The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform

The development of resources for clinical interpretation of cancer-associated genetic alterations has significantly lagged behind the technical developments enabling their detection in a time-and cost-efficient manner. The lack of scientific and informatics decision support for oncologists can lead...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Discov Today
Autori principali: Johnson, Amber M., Zeng, Jia, Bailey, Ann M., Holla, Vijaykumar, Litzenburger, Beate, Lara-Guerra, Humberto, Mills, Gordon B., Mendelsohn, John, Shaw, Kenna R., Meric-Bernstam, Funda
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648066/
https://ncbi.nlm.nih.gov/pubmed/26148707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2015.05.013
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi